Krebs Biochem Standalone March 2019 Net Sales at Rs 11.71 crore, up 14.75% Y-o-Y
May 21, 2019 / 10:23 AM IST
Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are:Net Sales at Rs 11.71 crore in March 2019 up 14.75% from Rs. 10.21 crore in March 2018.
Quarterly Net Loss at Rs. 5.21 crore in March 2019 up 30.3% from Rs. 7.47 crore in March 2018.
EBITDA stands negative at Rs. 2.24 crore in March 2019 up 52.03% from Rs. 4.67 crore in March 2018.
Krebs Biochem shares closed at 98.00 on May 20, 2019 (NSE) and has given -13.96% returns over the last 6 months and -40.61% over the last 12 months.
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'19 | Dec'18 | Mar'18 | | Net Sales/Income from operations | 8.52 | 9.35 | 6.22 | | Other Operating Income | 3.20 | 1.99 | 3.99 | | Total Income From Operations | 11.71 | 11.34 | 10.21 | | EXPENDITURE | | Consumption of Raw Materials | 4.35 | 7.04 | 5.34 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.96 | -1.09 | -1.71 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.88 | 4.13 | 5.16 | | Depreciation | 1.18 | 1.07 | 1.09 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 4.92 | 5.32 | 6.23 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -3.58 | -5.13 | -5.91 | | Other Income | 0.16 | 0.12 | 0.15 | | P/L Before Int., Excpt. Items & Tax | -3.42 | -5.00 | -5.76 | | Interest | 1.90 | 1.46 | 1.42 | | P/L Before Exceptional Items & Tax | -5.32 | -6.46 | -7.18 | | Exceptional Items | 0.11 | -- | -0.30 | | P/L Before Tax | -5.21 | -6.46 | -7.47 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -5.21 | -6.46 | -7.47 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.21 | -6.46 | -7.47 | | Equity Share Capital | 16.63 | 13.74 | 13.74 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.45 | -4.90 | -5.99 | | Diluted EPS | -4.16 | -4.90 | -5.99 | | EPS After Extra Ordinary | | Basic EPS | -3.45 | -4.90 | -5.99 | | Diluted EPS | -4.16 | -4.90 | -5.99 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Explained | Can US President Donald Trump’s impeachment drag down Wall Street? Watch more 
ITR 2019-20: Income tax refund not received yet? Here are ways to check status Watch more 
Ideas For Profit | Bharat Dynamics: Do robust order book, compelling valuations make it a good bet? Watch more 
Post-COVID-19 Job market | Hiring rises across board, digital roles see high demand: Report Watch more 
